Alzheimer's disease starting to be considered a treatable condition
The report says 158 therapies are in development and 8 Phase III trials will report results this year.
- On Tuesday, Alzheimer's Disease International released the World Alzheimer Report 2026, arguing that dementia research has entered a 'New Era' with clinical trials reaching unprecedented scientific momentum and diagnostic breakthroughs.
- Researchers previously viewed Alzheimer's disease as an inevitable, untreatable consequence of aging; the report argues that advances in understanding disease biology now enable earlier interventions and potential prevention.
- Currently, scientists are evaluating 158 potential therapies across 192 clinical trials worldwide, while emerging research suggests about 45 percent of dementia cases could be prevented by addressing 14 modifiable risk factors.
- Neuroradiologist Emer MacSweeney emphasized that many patients in early stages are 'being ignored and completely missed' because diagnostic access remains limited and awareness is low.
- With global dementia cases projected to surpass 139 million by 2050, the report concludes that ensuring equitable access to diagnostic tools across all populations is now critical.
13 Articles
13 Articles
According to the World Alzheimer Report 2026, the disease can no longer be described as intractable, thanks to recent advances in drugs, diagnosis and risk prevention. For decades, Alzheimer's disease has been seen as a virtually inevitable consequence of aging, for which medicine only offered control of symptoms. The World Alzheimer Report [...]
A WORLD report for 2026 states that Alzheimer's disease is no longer incurable. New drugs are slowing its progression, and prevention by reducing risk factors can delay or prevent many cases.
The "World Alzheimer's Report 2026," published by Alzheimer's Disease International, based in London, reveals rapid progress in the diagnosis and treatment of the disease, with projections indicating that the number of people living with dementia worldwide will exceed 139 million by 2050. The report highlights a shift in Alzheimer's research, moving from a focus on treating symptoms after they appear to early detection and attempting to slow its…
Coverage Details
Bias Distribution
- 43% of the sources are Center, 43% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
